Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Wallstrip: United Therapeutics Corp. (UTHR)
- Dr. Rothblatt started a company to save her daughter's life. United Therapeutics Corp. UTHR
- Videos 2008-10-22
Additional Resources
- Multex.com News - Multex ACE Consensus Estimates, Patriot American Hospitality Inc. -PAH-
- NEW YORK--BUSINESS WIRE--March 1, 1999--Wall Street expects net income for Patriot American Hospitality Inc. PAH will increase 23.8% in 1998 and 136.8% in 1999. For full report, please go to the Multex Investor Network. (http://www.multexinvestor.com//GetDocument.asp?docid=777829) You will be invited to register in order to view the full text of the...
- Research articles 1999-03-01
- EC proposes directive to phase out PAH tyre oils; BLIC requests a one-year delay in the imposition of proposed directive banning low-PAH tyre extender oils. The time needed to develop a test; and is to change formulations with OE customers.(News)(polycycl
- Byline: Patrick Raleigh Europe's tyre industry is urgently seeking changes to a European Commission proposal to ban polycyclic-aromatic-hydrocarbon-rich (PAH-rich) extender oils by the end of 2008. There are, however, major disagreements over the plan, which rubber industry group BLIC (Bureau de...
- Research articles 2004-04-01
- Ambrisentan Receives FDA Fast Track Designation for PAH Development
- DENVER -- Myogen, Inc. (Nasdaq:MYOG) today announced that the U.S. Food and Drug Administration FDA has granted Fast Track designation to ambrisentan, the Company's type-A selective endothelin receptor antagonist ERA, currently in Phase 3 clinical evaluation for the treatment of patients with pulmonary arterial hypertension PAH.
- Research articles 2006-03-09
- FDA Calendar Updates: United Therapeutics, Roche
- Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA....
- External links 2009-07-30
- Actelion Receives Frost & Sullivan 2007 North American Pulmonary Arterial Hypertension Market Leadership Award
- PALO ALTO, Calif. -- Frost & Sullivan today announced that it has awarded the 2007 North American Pulmonary Arterial Hypertension PAH Market Leadership of the Year Award to Actelion Pharmaceuticals US, Inc. According to Frost & Sullivan's research, Actelion is the key leader in the U.S. PAH market. Actelion's product...
- Research articles 2007-09-20
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A ...
- Research articles 2005-11-23
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2006-02-03
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2005-12-09
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2005-12-02
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2005-12-23
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2005-12-16
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2005-12-30
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2006-01-13
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.05 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A ...
- Research articles 2006-01-20
- Palladium.(FINANCIAL MARKETS)
- SYMBOL=PAH MAR.06 PALLADIUM NYMEX Each Horizontal Line = 5 Dollars 1 Pt. = $1.00 Minimum Move: 5 Pts. FND: 2-28-06 LTD: 3-29-06 OPTIONS EXPIRE: N/A High...
- Research articles 2006-01-27
- Gilead Submits New Drug Application To U.S. FDA for Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced the submission of a New Drug Application NDA to the U.S. Food and Drug Administration FDA for marketing approval of ambrisentan (5 mg and 10 mg) for the once-daily treatment of pulmonary arterial hypertension PAH. The application is supported by...
- Research articles 2006-12-18
- United Therapeutics' 10-Q Suggests Dangerous Over-Reliance on Its Top Product
- United Therapeutics Corp. derives almost all of its commercial sales from its top product Remodulin, a treatment for pulmonary arterial hypertension. In 2009, however, the biotechnology company could be drifting into troubled waters. For the six-months ended June 30, Remodulin accounted for approximately 95 percent of the $130.6 million in...
- Blog posts 2008-08-27
- Proteo, Inc./Proteo Biotech AG: European Commission grants Orphan Drug Status to Elafin for the treatment of PAH
- IRVINE, Calif. & KIEL, Germany -- Proteo, Inc. (OTCBB: PTEO; WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG announced today:
- Research articles 2007-03-29
- Patriot American Hospitality Closes on Purchase of Del Mar Hilton; REIT to Begin $1.1 Renovation of Guest Rooms and Public Areas
- DALLAS--BUSINESS WIRE--March 27, 1996--Patriot American Hospitality, Inc. (NYSE:PAH), one of the nation's largest hotel real estate investment trusts REIT, today announced it closed on the previously announced purchase of the 245-room Del Mar Hilton Hotel in San Diego, Calif. from an affiliate of a major insurance company for...
- Research articles 1996-03-27
- << Previous
- page 1 of 1
- Next >>
Presented by American Express